Variations in the Occurrence of the S315T Mutation Within thekatGGene in Isoniazid-Resistant ClinicalMycobacterium tuberculosisIsolates from Kuwait
- 1 June 2002
- journal article
- Published by Mary Ann Liebert Inc in Microbial Drug Resistance
- Vol. 8 (2), 99-105
- https://doi.org/10.1089/107662902760190644
Abstract
The worldwide threat of drug-resistant tuberculosis (TB) to human health has led to the development of molecular methods for rapidly determining the resistance of clinical Mycobacterium tuberculosis isolates to the two front-line antituberculous drugs, isoniazid and rifampin. The prevalence of the S315T mutation within the katG gene, which confers clinically significant resistance to isoniazid, was determined in isoniazid-resistant clinical M. tuberculosis isolates recovered from TB patients in Kuwait. A total of 67 isoniazid-resistant and 18 susceptible clinical M. tuberculosis isolates were tested. The mutation S315T was found in 46 (69%) of the 67 resistant strains, whereas none of the susceptible strains contained this mutation. The prevalence of this mutation was highest (32 of 40, 80%) in isolates recovered from patients of South Asian origin and lowest in isolates from patients of Middle Eastern origin (8 of 18, 44%). The genotyping performed on isolates carrying the S315T mutation showed that the isolates belong to several different types as they exhibited unique DNA banding patterns. The results point to a varying prevalence of the S315T mutation within the katG gene in clinical M. tuberculosis isolates recovered from patients of different ethnic groupings within the same country. The results also suggest that detection of the S315T mutation in the katG gene may be used as a rapid screening method for identifying isoniazid-resistant clinical M. tuberculosis isolates recovered from majority of patients in some ethnic groupings.Keywords
This publication has 28 references indexed in Scilit:
- Genetic Polymorphism at Codon 463 in the katG Gene in Isoniazid-Sensitive and -Resistant Isolates of Mycobacterium tuberculosis from the Middle EastMedical Principles and Practice, 2001
- Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence CommunityJournal of Clinical Microbiology, 2001
- Mutations at Amino Acid Position 315 of thekatGGene Are Associated with High‐Level Resistance to Isoniazid, Other Drug Resistance, and Successful Transmission ofMycobacterium tuberculosisin The NetherlandsThe Journal of Infectious Diseases, 2000
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Drug-Resistant Tuberculosis: Review of the Worldwide Situation and the WHO/IUATLD Global Surveillance ProjectClinical Infectious Diseases, 1997
- Site‐directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase–peroxidase activities and isoniazid resistanceMolecular Microbiology, 1996
- Temporal Trends And Transmission Patterns During The Emergence Of Multidrug-Resistant Tuberculosis In New York City: A Molecular Epidemiologic AssessmentThe Journal of Infectious Diseases, 1995
- Missense mutations in the catalase‐peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosisMolecular Microbiology, 1995
- Rapid Identification Of A Point Mutation Of The Mycobacterium tuberculosis Catalase-Peroxidase (katG) Gene Associated With Isoniazid ResistanceThe Journal of Infectious Diseases, 1995
- Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular studyThe Lancet, 1994